Kodiak Sciences (KOD) Income from Continuing Operations (2017 - 2026)
Kodiak Sciences (KOD) posted Income from Continuing Operations of 522549000.0 for Q1 2026, down 35.73% on a QoQ basis from 384978000.0 in Q4 2025, and down 780.19% year-over-year from 76824394.04 in Q1 2025.
Kodiak Sciences (KOD) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Kodiak Sciences' Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 522549000.0 for Q1 2026.
- Quarterly Income from Continuing Operations fell 780.19% year-over-year to 522549000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1195583000.0 (down 512.96% YoY) and the FY2025 annual result came in at 558153000.0, down 31.98% from the prior year.
- Income from Continuing Operations was 522549000.0 for Q1 2026 at Kodiak Sciences, down from 384978000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 44772000.0 in Q1 2024 and bottomed at 522549000.0 in Q1 2026.
- A 5-year average of 121159882.35 and a median of 71053000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations soared 84.3% — and 2026, when it plunged 780.19%.
- Kodiak Sciences' Income from Continuing Operations stood at 71053000.0 in 2022, then advanced by 15.04% to 60364000.0 in 2023, then grew by 25.54% to 44949000.0 in 2024, then tumbled by 756.48% to 384978000.0 in 2025, then sank by 35.73% to 522549000.0 in 2026.
- Business Quant data shows KOD's Income from Continuing Operations at 522549000.0 in Q1 2026, 384978000.0 in Q4 2025, and 228013000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | -522.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -522.55 Mn |
| Dec 31, 2025 | -384.98 Mn |
| Sep 30, 2025 | -228.01 Mn |
| Jun 30, 2025 | -60.04 Mn |
| Mar 31, 2025 | -59.37 Mn |
| Dec 31, 2024 | -44.95 Mn |
| Sep 30, 2024 | -45.11 Mn |
| Jun 30, 2024 | -45.62 Mn |
| Mar 31, 2024 | -44.77 Mn |
| Dec 31, 2023 | -60.36 Mn |
| Sep 30, 2023 | -50.31 Mn |
| Jun 30, 2023 | -85.17 Mn |
| Mar 31, 2023 | -74.50 Mn |
| Dec 31, 2022 | -71.05 Mn |
| Sep 30, 2022 | -83.64 Mn |
| Jun 30, 2022 | -97.02 Mn |
| Mar 31, 2022 | -102.26 Mn |
| Dec 31, 2021 | -93.03 Mn |
| Sep 30, 2021 | -498.78 Mn |
| Jun 30, 2021 | -502.79 Mn |